Form 4 for NRXP NRX Pharmaceuticals, Inc.

Accepted 2021-11-02 00:00:00 ET · period of report 2021-08-26 · accession 0000950142-21-003506 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-11-02	2021-08-26	NRXP	McMaster Herbert Raymond	Dir	M - OptEx	$2.22	+18.3K	18.3K	New	+$40.6K
D	2021-11-02	2021-08-26	NRXP	McMaster Herbert Raymond	Dir	C - Cnv Deriv	$2.22	-28.7K	16.4K	-64%	-$63.8K
D	2021-11-02	2021-08-26	NRXP	McMaster Herbert Raymond	Dir	A - Grant	$0.00	+10.4K	10.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-08-26	M	A	18,300	$2.22	18,300	D	—	—	(F1) The options are fully vested.
2	Derivative	Employee Stock Option (Right to buy)	2021-08-26	C	D	28,724	$2.22	16,362	D	$2.22 · — to 2028-01-04	28,724 Common Stock	(F1) The options are fully vested.
3	Derivative	Restricted Stock Units	2021-08-26	A	A	10,424	$0.00	10,424	D	— · — to —	10,424 Common Stock	(F2) Shares and restricted stock units acquired pursuant to the exercise of 28,724 vested stock options under the NRX Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan (the "Plan"). The Reporting person received 18,300 freely tradable shares of common stock, par value $0.001 per share, of NRX Pharmaceuticals, Inc. (the "Common Stock") and 10,424 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock. The restricted stock units remain in the Plan and are subject to forfeiture if the Earnout Share Milestone and the Earnout Cash Milestone (as defined in the Merger Agreement) do not occur on or prior to December 31, 2022.